Northwest Biotherapeutics (NWBO) Long-Term Investments (2014 - 2016)

Northwest Biotherapeutics' Long-Term Investments history runs 3 years deep, the most recent figure standing at $77000.0 for Q2 2016.

• In Q2 2016, Long-Term Investments fell 89.58% year-over-year to $77000.0; the TTM figure through Jun 2016 stood at $77000.0 (down 89.58% YoY), while the FY2015 annual figure was $349000.0, down 80.17% from the prior year.
• Long-Term Investments for Q2 2016 stood at $77000.0, down from $214000.0 in the prior quarter.
• The five-year high for Long-Term Investments was $1.8 million in Q4 2014, with the low at $77000.0 in Q2 2016.
• The 3-year median for Long-Term Investments is $488000.0 (2015), against an average of $706428.6.
• The sharpest annual moves came in 2015 and 2016: Long-Term Investments sank 80.17% in 2015, then sank 89.58% in 2016.
• Northwest Biotherapeutics' Long-Term Investments stood at $1.8 million in 2014, then tumbled by 80.17% to $349000.0 in 2015, then plunged by 77.94% to $77000.0 in 2016.
• Business Quant data shows NWBO's Long-Term Investments at $77000.0 in Q2 2016, $214000.0 in Q1 2016, and $349000.0 in Q4 2015.